Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Kati Ylitalo"'
Autor:
Juha Vakkilainen, Matti Jauhiainen, Kati Ylitalo, Ilpo O. Nuotio, Jorma S.A. Viikari, Christian Ehnholm, Marja-Riitta Taskinen
Publikováno v:
Journal of Lipid Research, Vol 43, Iss 4, Pp 598-603 (2002)
Small, dense LDL particles are typical for FCHL. Intravascular lipid exchange and net transfer among HDL, LDL, and triglyceride-rich lipoproteins as well as lipolysis in the VLDL-IDL-LDL cascade regulate properties of LDL. We investigated postheparin
Externí odkaz:
https://doaj.org/article/19cf7bc9beee48c8871edb4e446d2034
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 24:1492-1497
Objective— Oxidized low-density lipoprotein (Ox-LDL)is implicated in the pathogenesis of atherosclerosis. Circulating oxidation-specific epitopes on plasma Ox-LDL has been linked with coronary artery disease, but its determinants and its associatio
Autor:
Marja-Riitta Taskinen, Jukka T. Salonen, Hannele Yki-Järvinen, Kati Ylitalo, Aino Soro, Riitta Salonen, Jukka Westerbacka, C. Alagona
Publikováno v:
European Journal of Clinical Investigation. 33:457-463
BACKGROUND Low high-density lipoprotein cholesterol (HDL-C) is associated with increased risk for developing coronary artery disease. Cardiovascular disease is characterized by increased intima-media thickness (IMT) and arterial stiffness, but the ef
Publikováno v:
Atherosclerosis. 165:309-316
Low serum high-density lipoprotein cholesterol (HDL-C) is a strong predictor of coronary heart disease (CHD). The aim of the present study was to evaluate the metabolic parameters predicting the atherosclerotic changes in asymptomatic members of low
Autor:
Kati Ylitalo, I. Nuotio, Erkki Vartiainen, Veikko Salomaa, Leena Peltonen, Marja-Riitta Taskinen, Päivi Pajukanta, Heidi E. Lilja, Jorma Viikari, Aino Soro
Publikováno v:
Atherosclerosis. 164:103-111
In patients with premature coronary heart disease, the most common lipoprotein abnormality is high-density lipoprotein (HDL) deficiency. To assess the genetic background of the low HDL-cholesterol trait, we performed a candidate gene study in 25 fami
Autor:
Leena Peltonen, Markku Laakso, Jorma Viikari, Juha Vakkilainen, Rita M. Cantor, Petri T. Kovanen, S. Lahdenperä, Kati Ylitalo, Marja-Riitta Taskinen, Päivi Pajukanta, Jussi Pihlajamäki, Ilpo Nuotio
Publikováno v:
European Journal of Human Genetics. 10:547-552
The nature of the genetic and environmental factors influencing low density lipoprotein (LDL) particle size in patients with familial combined hyperlipidaemia (FCHL) is under debate. We measured LDL peak particle size in 553 subjects belonging to 48
Autor:
Jukka T. Salonen, I. Nuotio, Mikko Syvänne, Riitta Salonen, Marja-Riitta Taskinen, Kati Ylitalo
Publikováno v:
Atherosclerosis. 162:171-178
Background : Familial combined hyperlipidemia (FCHL) is the most common hereditary lipid disorder that predisposes the patients to premature coronary heart disease. Members of FCHL families are categorised as affected or unaffected according to serum
Publikováno v:
Metabolism. 51:664-670
This study aimed to assess the role of complement C3, hormone-sensitive lipase (HSL), and peroxisome proliferator-activated receptor gamma (PPARgamma) gene expression in familial combined hyperlipidemia (FCHL). mRNA expression of these 3 determinants
Autor:
Ilpo Nuotio, Juha Vakkilainen, Jorma Viikari, Matti Jauhiainen, Kati Ylitalo, Christian Ehnholm, Marja-Riitta Taskinen
Publikováno v:
Journal of Lipid Research, Vol 43, Iss 4, Pp 598-603 (2002)
Small, dense LDL particles are typical for FCHL. Intravascular lipid exchange and net transfer among HDL, LDL, and triglyceride-rich lipoproteins as well as lipolysis in the VLDL-IDL-LDL cascade regulate properties of LDL. We investigated postheparin
Autor:
Jorma Viikari, Kati Ylitalo, Marja-Riitta Taskinen, Miia Valkonen, S. Lahdenperä, Ming-Lin Liu, Ilpo Nuotio, Juha Vakkilainen
Publikováno v:
Annals of Medicine. 34:48-54
There is increasing evidence that oxidation of low-density lipoprotein (LDL) plays an important role in atherogenesis.To explore the LDL oxidizability and its determinants in familial combined hyperlipidemia (FCHL) patients with different phenotypes.